Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEFLUNOMIDE, with a corresponding US DMF Number 16038.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 07, 2013, and payment made on August 04, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II